HomeHYL • EBR
add
Hyloris Pharmaceuticals SA
Previous close
€6.35
Day range
€6.27 - €6.50
Year range
€2.89 - €11.95
Market cap
174.34M EUR
Avg Volume
17.15K
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.70M | 76.88% |
Operating expense | 3.71M | -35.08% |
Net income | -1.43M | 67.33% |
Net profit margin | -52.89 | 81.53% |
Earnings per share | — | — |
EBITDA | -609.50K | 85.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.15M | -21.86% |
Total assets | 41.34M | -13.31% |
Total liabilities | 9.19M | 6.73% |
Total equity | 32.14M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -6.49% | — |
Return on capital | -7.90% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.43M | 67.33% |
Cash from operations | -1.68M | 61.40% |
Cash from investing | -63.50K | -101.27% |
Cash from financing | -179.50K | -603.92% |
Net change in cash | -1.92M | -407.62% |
Free cash flow | -223.19K | 91.70% |
About
Founded
2012
Website
Employees
49
